Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand … equilibrium price effects of coupons, we employ individual-level data to estimate a discrete choice model of demand for multiple … sclerosis drugs. We use our demand estimates to parameterize a model of drug price negotiations. For this category of drugs, we …

and price. …

pharmaceutical pricing. The 2018 OECD report Pharmaceutical Innovation and Access to Medicines suggested that increased price … policy debate, the OECD undertook an exploration of the potential consequences of greater price transparency on market …

, given relatively high demand elasticities for pharmaceuticals in these populations; modest cash resources for health care …

This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the … pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …